Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 40Neoplasm Metastasis 7Leiomyosarcoma 7Liposarcoma 6Hemangiosarcoma 6Neurofibrosarcoma 5Sarcoma, Synovial 4Osteosarcoma 4Histiocytoma, Malignant Fibrous 4Glioblastoma 4Dermatofibrosarcoma 4Chondrosarcoma, Extraskeletal Myxoid 4Sarcoma, Alveolar Soft Part 3Neoplasms 3Gliosarcoma 3Gastrointestinal Stromal Tumors 3Fibrosarcoma 3Breast Neoplasms 3Brain Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Recurrence 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nerve Sheath Neoplasms 2Histiocytoma, Angiomatoid Fibrous 2Hemangioendothelioma, Epithelioid 2Granuloma, Plasma Cell 2Carcinoma, Renal Cell 2

Interventions

Cyclophosphamide 9Doxorubicin 8Vincristine 6Etoposide 6Ifosfamide 5Filgrastim 5Radiotherapy 4fludarabine phosphate 3Topotecan 3Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Cisplatin 3Carboplatin 3seclidemstat 2Temozolomide 2Tacrolimus 2Neoadjuvant Therapy 2Irinotecan 2Injections 2Hyperthermic Intraperitoneal Chemotherapy 2Granulocyte Colony-Stimulating Factor 2Epirubicin 2Dactinomycin 2Cytoreduction Surgical Procedures 2Cyclosporine 2Chemotherapy, Adjuvant 2Brachytherapy 2thymoglobulin 1tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × pazopanib × Sarcoma × Clear all
NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

OHSU Knight Cancer Institute

Phase 2 Completed
54 enrolled 12 charts
Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡